| Issue |
Title |
File |
| Vol 29, No 2 (2026) |
Efficacy and safety of bacterial-based cancer therapies: a meta-analysis of preclinical and clinical studies |
(Eng)
|
|
Singh V.K., Kumar A., Matreja P.S., Singh S.
|
| Vol 29, No 2 (2026) |
Autologous hematopoietic stem cell transplantation for neurological disorders: a systematic review & meta-analysis of clinical outcomes and complications |
(Eng)
|
|
Awasthi S., Singh V.K., Jain S.K., Sharma S.
|
| Vol 29, No 2 (2026) |
Wormwood: species diversity, regional sensitization features in Mongolia, new options for specific treatment |
(Rus)
|
|
Tuvshinbayar B., Maksimova A.V., Tataurschikova N.S., Pugoeva K.B.
|
| Vol 29, No 1 (2026) |
Comparison of Cytochemistry and Flow Cytometry for Leukemia Immunophenotyping: A Systematic Review & Meta-Analysis |
(Eng)
|
|
Kumar A., Matreja P., Singh V., Awasthi S.
|
| Vol 29, No 1 (2026) |
Physical exercise is the best therapy in reducing interleukin-6 levels as an inflammatory mediator: a systematic review |
(Eng)
|
|
Ayubi N., Wibawa J., Lobo J., Komaini A., Callixte C., Rizki A., Afandi A., Sabillah M.
|
| Vol 29, No 1 (2026) |
Schnitzler's syndrome, an underdiagnosed autoinflammatory disease: current and future perspective |
(Eng)
|
|
Jakhar M., Rani N., Singh R., Singh T.
|
| Vol 29, No 1 (2026) |
Comparative characteristics of different endotypes in chronic rhinosinusitis |
(Rus)
|
|
Lazareva A.M., Smirnova O.V.
|
| Vol 29, No 1 (2026) |
The issues of the neuro-immuno-endocrine system theory |
(Rus)
|
|
Chereshnev V.A., Yushkov B.G.
|
| Vol 26, No 2 (2023) |
Natural and synthetic peptides in antimicrobial therapy |
(Rus)
|
|
Khlystova K.A., Sarkisyan N.G., Kataeva N.N.
|
| Vol 25, No 1 (2022) |
Immune-hormonal imbalance in chemical cancerogenesis |
(Rus)
|
|
Glushkov A.N.
|
| Vol 25, No 1 (2022) |
Macrophages in gouty inflammation |
(Rus)
|
|
Malyshev I.Y., Chernysheva O.O., Kuznetsova L.V., Pikhlak A.E.
|
| Vol 23, No 1 (2020) |
TYPE 2 DIABETES MELLITUS – AN AUTOIMMUNE DISEASE? |
(Rus)
|
|
Asfandiyarova N.S.
|
| Vol 23, No 1 (2020) |
PATHOGENETIC MECHANISM OF ACNE-COUPLED INFLAMMATION |
(Rus)
|
|
Rumyantsev A.G., Demina O.M., Raikina E.V.
|
| Vol 22, No 4 (2019) |
IMMUNE RESPONSES TO HERPESVIRUSES AND MULTIPLE SCLEROSIS |
(Rus)
|
|
Zheleznikova G.F., Skripchenko N.V., Alekseeva L.A., Skripchenko E.Y.
|
| Vol 21, No 4 (2018) |
Conceptualization of Human Skin Cells Subpopulations States |
(Rus)
|
|
Goltsov S..., Teslinov A...
|
| Vol 21, No 2 (2018) |
HOMEOSTATIC PROLIFERATION: FROM HEALTH TO PATHOLOGY |
(Rus)
|
|
Shevyrev D.V., Tereshchenko V.P., Kozlov V.A.
|
| Vol 21, No 2 (2018) |
INTERLEUKIN‑7 |
(Rus)
|
|
Eremina O.F., Balmasova I.P., Gultyaev M.M., Gluhoedova N.V., Yushchuk N.D.
|
| Vol 21, No 1 (2018) |
CO-INHIBITORY MOLECULES IN NORMAL AND PATHOLOGICAL CONDITIONS. IMMONOLOGICAL CHECKPOINTS. Part 2. Co-inhibitory molecules part in oncology and infectious diseases. Checkpoints’ blockers monoclonal antibodies |
(Rus)
|
|
Toptygina A.P.
|
| Vol 21, No 1 (2018) |
MORPHOFUNCTIONAL CHARACTERISTICS OF THE PROTECTIVE MECHANISMS OF NEUTROPHILS AGAINST BACTERIAL INFECTIONS AND THEIR CONTRIBUTION IN THE PATHOGENESIS OF PRO-INFLAMMATORY REACTIONS |
(Rus)
|
|
Matosova E.V., Andryukov B.G.
|
| Vol 20, No 4 (2017) |
CO-INHIBITORY MOLECULES IN NORMAL AND PATHOLOGICAL CONDITIONS. IMMONOLOGICAL CHECKPOINTS Part 1. Role of co-inhibitory molecules in normal immune response and in allergy and autoimmune diseases |
(Rus)
|
|
Toptygina A.P.
|
| Vol 20, No 4 (2017) |
CHEMOKINES IN THE PATHOGENESIS OF MULTIPLE SCLEROSIS |
(Rus)
|
|
Zheleznikova G.F., Skripchenko N.V., Alekseeva L.A., Skripchenko E.Y.
|
| Vol 20, No 4 (2017) |
INFLAMMASOMES AND INFLAMMATION |
(Rus)
|
|
Garib F.Y., Rizopulu A.P.
|
| Vol 20, No 1 (2017) |
CYTOKINES OF ADAPTIVE IMMUNITY IN THE PATHOGENESIS OF MULTIPLE SCLEROSIS |
(Rus)
|
|
Zheleznikova G.F., Skripchenko N.V., Alekseeva L.A., Skripchenko E.Y.
|
| 1 - 23 of 23 Items |
|
СМИ зарегистрировано Федеральной службой по надзору в сфере связи, информационных технологий и массовых коммуникаций (Роскомнадзор).